First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Solomon et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d70aca99397875bbaa82ce — DOI: https://doi.org/10.1056/nejmoa1408440

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Correcting for non-compliance in randomized trials using rank preserving structural failure time models· 1991 · 428 citations
2. COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER· 2002 · 3,739 citations
3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer· 2002 · 4,975 citations
4. Toxicity and response criteria of the Eastern Cooperative Oncology Group· 1982 · 11,560 citations
5. G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS Patients· 1992 · 338 citations